February 07, 2026 09:34 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Big call from RBI: Repo rate stays at 5.25%, neutral stance continues | RG Kar scam twist: Court issues non-bailable warrant against whistle-blower Akhtar Ali | Court snub for Vijay: Madras HC rejects plea in ₹1.5 crore tax case | ‘We never said no’: Suryakumar Yadav says India ready for Pakistan clash at T20 World Cup | Supreme Court orders Mamata govt to clear pending dues | ‘India is free to buy oil from anyone’: Russia fires back at Trump’s crude deal claim | ‘Justice crying behind closed doors’: Mamata Banerjee slams ECI in Supreme Court, CJI Kant assures solution | Mummy, Papa, sorry: Three sisters jump to death after parents object to online gaming | Supreme Court raps Meta, WhatsApp: ‘Theft of private information, won’t allow its use’ | ‘Completely surrendered’: Congress slams Modi after Trump’s trade deal move
Coronavirus Vaccine

Covid vaccine approval likely soon : DCGI

| @indiablooms | Dec 31, 2020, at 11:29 pm

New Delhi/IBNS: The coronavirus vaccines awaiting approval can be cleared soon, India's drug control authority said Thursday.

Drugs Controller General Dr VG Somani said today in a webinar that probably there will be "a happy new year with something in hand".

Somani's assurance came a day ahead of the crucial meeting of the expert panel to authorise emergency use of vaccines made by Serum Institute of India, Bharat Biotech and Pfizer, said reports.

The Centre had formed an expert panel to examine the application of emergency vaccine approval by the drug companies.

Serum Institute is manufacturing Covishield developed by Oxford University and Pharma major AstraZeneca while Bharat Biotech is manufacturing Covaxin partnering with Indian Council of Medical Research (ICMR).

Reports said both the firms have made the presentations before the panel but Pfizer is yet to present the data.

Once cleared by the expert panel, the applications will go to the DCGI for approval. An NDTV report said that officials have said the Oxford vaccine is likely to get approval first.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.